Mukherjee, A.; Bandyopadhyay, D.
Correction: Mukherjee, A.; Bandyopadhyay, D. Targeted Therapy in Breast Cancer: Advantages and Advancements of Antibody–Drug Conjugates, a Type of Chemo-Biologic Hybrid Drugs. Cancers 2024, 16, 3517. Cancers 2025, 17, 1633.
https://doi.org/10.3390/cancers17101633
AMA Style
Mukherjee A, Bandyopadhyay D.
Correction: Mukherjee, A.; Bandyopadhyay, D. Targeted Therapy in Breast Cancer: Advantages and Advancements of Antibody–Drug Conjugates, a Type of Chemo-Biologic Hybrid Drugs. Cancers 2024, 16, 3517. Cancers. 2025; 17(10):1633.
https://doi.org/10.3390/cancers17101633
Chicago/Turabian Style
Mukherjee, Attrayo, and Debasish Bandyopadhyay.
2025. "Correction: Mukherjee, A.; Bandyopadhyay, D. Targeted Therapy in Breast Cancer: Advantages and Advancements of Antibody–Drug Conjugates, a Type of Chemo-Biologic Hybrid Drugs. Cancers 2024, 16, 3517" Cancers 17, no. 10: 1633.
https://doi.org/10.3390/cancers17101633
APA Style
Mukherjee, A., & Bandyopadhyay, D.
(2025). Correction: Mukherjee, A.; Bandyopadhyay, D. Targeted Therapy in Breast Cancer: Advantages and Advancements of Antibody–Drug Conjugates, a Type of Chemo-Biologic Hybrid Drugs. Cancers 2024, 16, 3517. Cancers, 17(10), 1633.
https://doi.org/10.3390/cancers17101633